298 related articles for article (PubMed ID: 38046068)
1. Prevention of Oncogenic
Atamna A; Yahav D; Hirzel C
Transpl Int; 2023; 36():11856. PubMed ID: 38046068
[TBL] [Abstract][Full Text] [Related]
2. Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients.
Cesarman E
Cancer Lett; 2011 Jun; 305(2):163-74. PubMed ID: 21493001
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus reactivation influences clonal evolution in human herpesvirus-8-related lymphoproliferative disorders.
Granai M; Facchetti M; Mancini V; Goedhals J; Sherriff A; Mundo L; Bellan C; Amato T; Sorrentino E; Ungari M; Raphael M; Leoncini L; Facchetti F; Lazzi S
Histopathology; 2021 Dec; 79(6):1099-1107. PubMed ID: 34431125
[TBL] [Abstract][Full Text] [Related]
4. Infections caused by herpes viruses other than cytomegalovirus in solid organ transplant recipients.
Carratalà J; Montejo M; Pérez-Romero P
Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():63-9. PubMed ID: 22542037
[TBL] [Abstract][Full Text] [Related]
5. Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation.
Chiereghin A; Barozzi P; Petrisli E; Piccirilli G; Gabrielli L; Riva G; Potenza L; Cappelli G; De Ruvo N; Libri I; Maggiore U; Morelli MC; Potena L; Todeschini P; Gibertoni D; Labanti M; Sangiorgi G; La Manna G; Pinna AD; Luppi M; Lazzarotto T
Transplantation; 2017 Aug; 101(8):1935-1944. PubMed ID: 28333859
[TBL] [Abstract][Full Text] [Related]
6. A Focused Review of Epstein-Barr Virus Infections and PTLD in Pediatric Transplant Recipients: Guidance From the IPTA and ECIL Guidelines.
Yamada M; L'Huillier AG; Green M
J Pediatric Infect Dis Soc; 2024 Feb; 13(Supplement_1):S31-S38. PubMed ID: 38417085
[TBL] [Abstract][Full Text] [Related]
7. Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial.
Mahadeo KM; Baiocchi R; Beitinjaneh A; Chaganti S; Choquet S; Dierickx D; Dinavahi R; Duan X; Gamelin L; Ghobadi A; Guzman-Becerra N; Joshi M; Mehta A; Navarro WH; Nikiforow S; O'Reilly RJ; Reshef R; Ruiz F; Spindler T; Prockop S
Lancet Oncol; 2024 Mar; 25(3):376-387. PubMed ID: 38309282
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
San-Juan R; Comoli P; Caillard S; Moulin B; Hirsch HH; Meylan P;
Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():109-18. PubMed ID: 24475976
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic γ Herpesviruses EBV and HHV8 in Kidney Transplantation.
Le J
Semin Nephrol; 2016 Sep; 36(5):362-371. PubMed ID: 27772621
[TBL] [Abstract][Full Text] [Related]
10. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients.
Riddler SA; Breinig MC; McKnight JL
Blood; 1994 Aug; 84(3):972-84. PubMed ID: 8043879
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology Frontiers in γ-Herpesviruses Treatments.
Granato M
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768838
[TBL] [Abstract][Full Text] [Related]
12. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
Tan HH; Goh CL
Am J Clin Dermatol; 2006; 7(1):13-29. PubMed ID: 16489840
[TBL] [Abstract][Full Text] [Related]
13. High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders.
Baldanti F; Grossi P; Furione M; Simoncini L; Sarasini A; Comoli P; Maccario R; Fiocchi R; Gerna G
J Clin Microbiol; 2000 Feb; 38(2):613-9. PubMed ID: 10655355
[TBL] [Abstract][Full Text] [Related]
14. AIDS-Associated Malignancies.
Vangipuram R; Tyring SK
Cancer Treat Res; 2019; 177():1-21. PubMed ID: 30523619
[TBL] [Abstract][Full Text] [Related]
15. Cancers associated with human gammaherpesviruses.
Wen KW; Wang L; Menke JR; Damania B
FEBS J; 2022 Dec; 289(24):7631-7669. PubMed ID: 34536980
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr Virus DNAemia and post-transplant lymphoproliferative disorder in pediatric solid organ transplant recipients.
Chang YC; Young RR; Mavis AM; Chambers ET; Kirmani S; Kelly MS; Kalu IC; Smith MJ; Lugo DJ
PLoS One; 2022; 17(10):e0269766. PubMed ID: 36256635
[TBL] [Abstract][Full Text] [Related]
17. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Allen UD; Preiksaitis JK;
Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381
[TBL] [Abstract][Full Text] [Related]
18. Human herpesvirus 8-positive multicentric Castleman disease with germinotropic plasmablastic aggregates: Overlapping spectrum of human herpesvirus 8-associated lymphoproliferative disorder.
Nakaya Y; Ishii N; Kasamatsu Y; Shimizu K; Tatsumi N; Tsutsumi M; Yoshida M; Yoshimura T; Hayashi Y; Nakao T; Inoue T; Yamane T
Pathol Int; 2020 Aug; 70(8):574-580. PubMed ID: 32449234
[TBL] [Abstract][Full Text] [Related]
19. Lymphoproliferative disorders with concurrent HHV8 and EBV infection: beyond primary effusion lymphoma and germinotropic lymphoproliferative disorder.
Wang W; Kanagal-Shamanna R; Medeiros LJ
Histopathology; 2018 Apr; 72(5):855-861. PubMed ID: 29105119
[TBL] [Abstract][Full Text] [Related]
20. The IPTA Nashville Consensus Conference on Post-Transplant lymphoproliferative disorders after solid organ transplantation in children: III - Consensus guidelines for Epstein-Barr virus load and other biomarker monitoring.
Preiksaitis J; Allen U; Bollard CM; Dharnidharka VR; Dulek DE; Green M; Martinez OM; Metes DM; Michaels MG; Smets F; Chinnock RE; Comoli P; Danziger-Isakov L; Dipchand AI; Esquivel CO; Ferry JA; Gross TG; Hayashi RJ; Höcker B; L'Huillier AG; Marks SD; Mazariegos GV; Squires J; Swerdlow SH; Trappe RU; Visner G; Webber SA; Wilkinson JD; Maecker-Kolhoff B
Pediatr Transplant; 2024 Feb; 28(1):e14471. PubMed ID: 37294621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
